<DOC>
	<DOCNO>NCT00328952</DOCNO>
	<brief_summary>The purpose study evaluate change various aspect auditory verbal hallucination 24-week antipsychotic treatment naturalistic condition .</brief_summary>
	<brief_title>Changes Auditory Verbal Hallucination During Atypical Antipsychotic Treatment Patients With Schizophrenia</brief_title>
	<detailed_description>Auditory verbal hallucination ( AVH ) , mean experience hearing voice , occur 60-75 % patient schizophrenia . Patients experience persistent AVH tend interrupt daily routine trouble keep regular job due intrusiveness abusive content voice . In addition , auditory hallucination report remain even disappearance psychotic symptom many patient schizophrenia spectrum disorder treatment typical antipsychotic . The study involve detailed phenomenological assessment AVH psychotic symptom , well side effect atypical antipsychotic .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Hallucinations</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Male female patient , 1565 year age Patients must diagnosis schizophrenia accord Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSMIV ) &gt; Patients experience vivid AVH confirm score 4 use hallucinatory behavior item Positive And Negative Syndrome Scale ( PANSS ) . Patients drugnaive drugfree 4 week . Patients schedule receive atypical antipsychotic medication . Each patient must provide write informed consent full explanation study protocol , authorized legal guardian must understand nature study must also give assent study participation . Subjects fluent Korean . DSMIV substance ( except nicotine caffeine ) dependence within past 1 year . Mental retardation ( IQ &lt; 70 ) . Neurological disorder include epilepsy , stroke , severe head trauma . Clinically significant laboratory abnormality , follow test : CBC differential , electrolytes , BUN , creatinine , hepatic transaminase , urinalysis EKG . Treatment injectable depot neuroleptic within less three dose interval last depot neuroleptic injection baseline . History electroconvulsive therapy transcranial magnetic stimulation within past 3 month . Subjects fluent Korean .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>auditory verbal hallucination</keyword>
	<keyword>antipsychotic treatment</keyword>
</DOC>